Leonardo Alfredo Ancora obtained his master degree in Economy, International Finance and Risk Management (2015) at University of Rome “La Sapienza”. His graduation work was on a model that uses artificial neural networks to forecast stock prices in the financial market (Eni and Luxottica), in collaboration with the Semeion research centre in Rome, under the supervision of Professor Massimo Buscema. After his graduation, he collaborated in several projects in the technology strategy and architecture area working as professional consultant for Blue Consulting (2016) and Deloitte Consulting (2017). His tasks were firstly addressed to the implementation of security policies, risk analysis, and process governance for an Insurance firm; secondly, he was involved in Demand Management activities for the major telco company operating in Italy. Finally, he started his journey in Lisbon for Bold International (2018) working in the artificial intelligence department for one of the biggest banks in Europe. Here he participated in implementing robot process automation for back-office operations, creation of automated report structuring using Natural Language Technology and developing an A.I. powered chatbot across the organization.
He achieved both IBM AI and Data Science certification (2020). His first publication regards the ML model application over the efficacy/tolerance of a drug in a prostate cancer treatment. At the moment he's a researcher at the Faculty of Medicine of Lisbon.
Leonardo Alfredo Ancora obtained his master degree in Economy, International Finance and Risk Management (2015) at University of Rome “La Sapienza”. His graduation work was on a model that uses artificial neural networks to forecast stock prices in the financial market (Eni and Luxottica), in collaboration with the Semeion research centre in Rome, under the supervision of Professor Massimo Buscema. After his graduation, he collaborated in several projects in the technology strategy and architecture area working as professional consultant for Blue Consulting (2016) and Deloitte Consulting (2017). His tasks were firstly addressed to the implementation of security policies, risk analysis, and process governance for an Insurance firm; secondly, he was involved in Demand Management activities for the major telco company operating in Italy. Finally, he started his journey in Lisbon for Bold International (2018) working in the artificial intelligence department for one of the biggest banks in Europe. Here he participated in implementing robot process automation for back-office operations, creation of automated report structuring using Natural Language Technology and developing an A.I. powered chatbot across the organization.
He achieved both IBM AI and Data Science certification (2020). His first publication regards the ML model application over the efficacy/tolerance of a drug in a prostate cancer treatment. At the moment he's a researcher at the Faculty of Medicine of Lisbon.